155 results on '"Bulato C"'
Search Results
2. OC 07.3 In vitro and ex vivo Rescue of a Nonsense Mutation (F5 p.Arg1161Ter) Responsible for Severe Coagulation Factor V Deficiency
3. Genetic modulation of the FVLeiden/normal FV ratio and risk of venous thrombosis in factor V Leiden heterozygotes
4. Increased platelet aggregation in decompensated cirrhosis indicates higher risks of further decompensation and liver-related mortality
5. Circulating microparticles in deficiency of the natural anticoagulants: OR172
6. The incidence of VTE in asymptomatic carriers of a deficiency of at, PC OR PS: a prospective cohort study: OR078
7. Characterization of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency
8. PO-29 Plasma levels of procoagulant and anticoagulant factors in patients with acute cancer-associated thrombosis
9. Thrombin generation assay in a patient with acquired factor V deficiency: PB 3.54–5
10. Characterisation of an apparently synonymous F5 mutation causing aberrant splicing and factor V deficiency: OC 50.4
11. Whole blood rotation thromboelastometry (ROTEM®) in nine severe factor V deficient patients and evaluation of the role of intraplatelets factor V
12. Platelet factor V levels in moderate to severe congenital factor V deficiency
13. Acute kidney injury is associated with reversible platelet dysfunction in hospitalized patients with decompensated cirrhosis
14. Direct correlation between platelet and plasma factor V levels in homozygous and heterozygous factor V deficient subjects: OC-MO-121
15. Evidence of the first X-linked thrombophilia due to a novel mutation in clotting factor IX gene resulting in hyperfunctional fix: factor IX arginine 338 leucine (factor IX padua): PL-TU-004
16. Coagulation monitoring of severe haemophilia A patient undergoing emicizumab therapy
17. Circulating microparticles in pregnant patients with primary antiphospholipid antibody syndrome
18. New generation flow-cytometry to measure circulating microvesiscles in cancer
19. Predictors of cancer-associated thrombosis in gastro-intestinal cancer: preliminary results
20. “In vitro” correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate
21. Circulating microparticles in pregnant patients with primary anti-phospholipid syndrome: an exploratory study
22. PLATELET AND PLASMA FACTOR XIII LEVELS AFTER REPLACEMENT THERAPY IN SEVERE CONGENITAL FACTOR XIII DEFICIENCY: IS THERE A ROLE FOR FACTOR XIII UPTAKE BY MEGAKARYOCYTES?
23. P-046: Circulating microparticles in pregnant patients with primary antiphospholipid antibody syndrome
24. P-047: Circulating microparticles in women with polycystic ovary syndrome: preliminary results
25. The incidence of VTE in asymptomatic carriers of a deficiency of at, PC OR PS: a prospective cohort study
26. Activation of human protein C by alpha 1,3-galctosyltransferase gene-knockout porcine aortic endothelial cells expressing human thrombomodulin
27. Circulating procoagulant microparticles in obese patients before and after weight loss
28. Endothelial microparticles in pre-eclamspia: a case-control study
29. Whole Blood Thromboelastometry Profile in Renal Pig-To Monkey Xenotransplantation
30. The Malmo polymorphism of coagulation factor IX (FIX) and the risk of venous thrombosis
31. WHOLE BLOOD THROMBOELASTOMETRY (ROTEM (R)) PROFILE IN NORMAL PREGNANCY
32. Circulating Microparticles plasma levels in Cynomolgus monkeys recipients of porcine neuronal xenograft
33. Effects of warfarin and vitamin k in PS synthesis by megakaryocyte cultures
34. INCREASED THROMBIN GENERATION DURING NORMAL PREGNANCY
35. Factor VIIa-antithrombin complexes plasma levels in preeclamptic women
36. Comparison of thrombin generation in transplanted primates recipients of pig hDaf or hDaf- GalT-KO kidney
37. Endothelial protein C receptor plays an important role in protein C activation by endothelial cells in xenografts
38. Severe factor V deficiency associated with a homozygous F65 deep-intronic splicing mutation
39. Pig endothelial cells expressing human thrombomodulin and endothelial protein C receptor and thrombin generation
40. Porcine endot5helial cells trsgenic for human endothelial protein C receptor and/or thrombomodulin generate different levels of human activated protein C
41. Circulating microparticles plasma levels in primates recipients of hDAF and GalT-KO pig kidney
42. Thrombin activatable fibrinolysis inhibitor system in cancer patients with or without venous thromboembolism
43. Profilo tromboelastografico in nove soggetti con difetto grave (omozigote) di fattore V
44. Circulating Microparticles plasma levels in Cynomolgus monkeys recipients of porcine kidneys
45. Cultured megakaryocytes of severe FV deficiency subjects endocytose FV
46. Role of human Protein C receptor (hEPCR) on activation of Protein C on transgenic porcine aortic endothelial cells expressing human thrombomodulin and hEPCR
47. Multiple electrode platelet aggregometry (Multiplate) in Cynomolgus monkeys )Macaca fascicularis)
48. Endothelial circulating microparticles in thromboembolism and cancer
49. Different levels of human activated protein C in GalT-KO-PAEC expressing human EPCR and/or human thrombomodulin
50. Porcine endothelial cells transgenic for human endothelial protein C receptor and/or thrombomodulin produce different levels of human activated protein C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.